Article Information
History
- June 1, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Patricia C. Mazzonetto1,2,
- Darine Villela2,
- Silvia Souza da Costa1,
- Ana C. V. Krepischi1,
- Fernanda Milanezi2,
- Michele P. Migliavacca2,
- Paulo M. Pierry2,
- Adriano Bonaldi2,
- Luiz Gustavo D. Almeida2,
- Camila Alves De Souza2,
- José Eduardo Kroll2,
- Marcelo G. Paula2,
- Rodrigo Guarischi-Sousa2,
- Cristovam Scapulatempo-Neto2 and
- Carla Rosenberg1,2,*
- 1The Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, São Paulo, SP, Brazil
- 2Diagnósticos da América S.A., DASA, São Paulo, Brazil
- ↵*Corresponding author: Carla Rosenberg, PhD, Department of Genetics and Evolutionary Biology, Institute of Biosciences, University of São Paulo, Rua do Matão 277, 05508-090, São Paulo-SP, Brazil. Phone Number: +55 1130917573. E-mail: carlarosenberg{at}ib.usp.br.
Posted June 01, 2023.
Low-pass whole genome sequencing is a reliable and cost-effective approach for copy number variant analysis in the clinical setting
